COMPASS Pathways plc
Develops psilocybin treatments for difficult-to-treat mental health conditions.
CMPS | US
Overview
Corporate Details
- ISIN(s):
- US20451W1018
- LEI:
- Country:
- United States of America
- Address:
- 3RD FLOOR, 1 ASHLEY ROAD, CHESIRE
- Website:
- https://compasspathways.com/
- Sector:
- Manufacturing
Description
COMPASS Pathways plc is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is developing its investigational COMP360 psilocybin treatment for difficult-to-treat mental health conditions. Its research and clinical trials focus on applications for treatment-resistant depression (TRD), post-traumatic stress disorder (PTSD), and anorexia nervosa.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
|
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB
Full Filing History RestrictedAccess to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset. |
|||||
Automate Your Workflow. Get a real-time feed of all COMPASS Pathways plc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for COMPASS Pathways plc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for COMPASS Pathways plc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
